Home
NRXPW
NRXPW News

Latest NRX Pharmaceuticals Inc. Warrant (NRXPW) News on July 27, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

PR Newswire

a month ago

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing

PR Newswire

a month ago

NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024

PR Newswire

a month ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors

PR Newswire

a month ago

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

PR Newswire

2 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Publishes Shareholder Update Letter

NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipolar Depression

PR Newswire

2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression At the American Society of Clinical Psychopharmacology Annual Meeting: NRX-101 is the First Oral Antidepressant Demonstrated to Reduce Suicidality in Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update

PR Newswire

2 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2024 Financial Results and Provides Business Update

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update

ACCESSWIRE

3 months ago

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024

PR Newswire

3 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Participate in the EF Hutton Annual Global Conference on May 15, 2024

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024

PR Newswire

3 months ago

NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Report First Quarter 2024 Financial Results on May 14, 2024

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

PR Newswire

3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

PR Newswire

3 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

PR Newswire

3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

PR Newswire

3 months ago

NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

PR Newswire

3 months ago

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections

PR Newswire

3 months ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)

PR Newswire

3 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

PR Newswire

4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

PR Newswire

4 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

PR Newswire

4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

PR Newswire

4 months ago

NRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

PR Newswire

4 months ago

UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK

PR Newswire

4 months ago

NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024

PR Newswire

4 months ago

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024

NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders

PR Newswire

4 months ago

NRx Pharmaceuticals Announces Results of the Vote Held During the Special Meeting of Shareholders

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders

PR Newswire

4 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales

PR Newswire

5 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales

NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

PR Newswire

5 months ago

NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

PR Newswire

5 months ago

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock

Simply Wall St.

5 months ago

Positive Signs As Multiple Insiders Buy NRx Pharmaceuticals Stock

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share

PR Newswire

5 months ago

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Common, Unregistered Shares at $0.38 per Share

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

PR Newswire

5 months ago

NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million Underwritten Public Offering of Common Stock Together with investor Commitment for Additional $1 million

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

PR Newswire

5 months ago

NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

PR Newswire

5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

PR Newswire

5 months ago

NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE Therapeutics, Inc. at the BIO CEO & Investor Conference 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

PR Newswire

5 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance of $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by Strategic Partner Lotus Pharmaceutical Co. Ltd. (1975.TW) in Recent Financial Report

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the Incorporation of HOPE Therapeutics, Inc., and Planned Share Dividend/Royalty Coupon

Dr. Mazen Iskandar Earns Surgeon of Excellence in Hernia Surgery Accreditation from SRC

GlobeNewswire

6 months ago

Dr. Mazen Iskandar Earns Surgeon of Excellence in Hernia Surgery Accreditation from SRC

TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'

PR Newswire

6 months ago

TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'

What Are the Capital Gains Tax Rates? How Can I Avoid Paying Them?

SmartAsset

6 months ago

What Are the Capital Gains Tax Rates? How Can I Avoid Paying Them?

First Citizens BancShares Declares Dividends

PR Newswire

6 months ago

First Citizens BancShares Declares Dividends

Business Wire

6 months ago

SBA Communications Completes $4.05 Billion Senior Secured Financing

C3is Inc. Announces Closing of $7.0 Million Upsized Underwritten Public Offering

GlobeNewswire

6 months ago

C3is Inc. Announces Closing of $7.0 Million Upsized Underwritten Public Offering

Business Wire

6 months ago

SBA Communications Corporation Announces Tax Reporting Information for 2023 Distributions

Reuters

6 months ago

Zions Bancorp sees slight decline in 2024 interest income, Q4 profit falls

SEC Probes B. Riley Deals With Client Tied to Failed Fund

Bloomberg

6 months ago

SEC Probes B. Riley Deals With Client Tied to Failed Fund

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

3 Tower REITs With Yields Up to 5.8%

Benzinga

6 months ago

3 Tower REITs With Yields Up to 5.8%

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

GlobeNewswire

6 months ago

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis

PR Newswire

6 months ago

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis

WiSA Technologies to Present at the Sequire Investor Summit in Puerto Rico

Business Wire

6 months ago

WiSA Technologies to Present at the Sequire Investor Summit in Puerto Rico

Eagle Point Credit Company Inc. Prices Offering of Preferred Stock

Business Wire

6 months ago

Eagle Point Credit Company Inc. Prices Offering of Preferred Stock

Rigetti Computing Awarded Innovate UK Grant to Develop Quantum Machine Learning Techniques for Financial Data Streams

GlobeNewswire

6 months ago

Rigetti Computing Awarded Innovate UK Grant to Develop Quantum Machine Learning Techniques for Financial Data Streams

Spring Valley Acquisition Corp. II Announces Preliminary Redemption Results

Business Wire

7 months ago

Spring Valley Acquisition Corp. II Announces Preliminary Redemption Results

Signing Day Sports Enters into Common Stock Purchase Agreement with Tumim Stone Capital LLC to Support Strategic Opportunities and Future Growth Initiatives

GlobeNewswire

7 months ago

Signing Day Sports Enters into Common Stock Purchase Agreement with Tumim Stone Capital LLC to Support Strategic Opportunities and Future Growth Initiatives

Horizon Aircraft Announces Board of Directors for Post-Merger Public Company

GlobeNewswire

7 months ago

Horizon Aircraft Announces Board of Directors for Post-Merger Public Company

NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco

PR Newswire

7 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco

NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard

PR Newswire

7 months ago

NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

GlobeNewswire

7 months ago

Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results

NRx Pharmaceuticals Announces the Election of Janet Rehnquist to its Board of Directors

PR Newswire

7 months ago

NRx Pharmaceuticals Announces the Election of Janet Rehnquist to its Board of Directors

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time

GlobeNewswire

7 months ago

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression

PR Newswire

7 months ago

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression

XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors

GlobeNewswire

7 months ago

XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS

PR Newswire

8 months ago

Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast Cancer in a Podium Poster Spotlight Discussion at the 2023 SABCS

UPDATE -- Babcock develops cutting-edge communications and control technology in partnership with Arqit

GlobeNewswire

8 months ago

UPDATE -- Babcock develops cutting-edge communications and control technology in partnership with Arqit

Pineapple Energy Participates in Bank of America’s 2023 Renewables Conference and Janney’s Clean Energy Investment Symposium

GlobeNewswire

8 months ago

Pineapple Energy Participates in Bank of America’s 2023 Renewables Conference and Janney’s Clean Energy Investment Symposium

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

PR Newswire

8 months ago

NeuroSense's Phase 2b ALS Trial Achieves Primary Safety and Tolerability & Secondary Clinical Efficacy Endpoints

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

GlobeNewswire

8 months ago

Yoshitsu Co., Ltd Announces the Launch of its U.S. Direct-Sale Store in Seattle’s University District

Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product

ACCESSWIRE

8 months ago

Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product

Associated Press Finance

8 months ago

StealthGas: Q3 Earnings Snapshot

STEALTHGAS INC. Reports Third Quarter and Nine Months 2023 Financial and Operating Results

GlobeNewswire

8 months ago

STEALTHGAS INC. Reports Third Quarter and Nine Months 2023 Financial and Operating Results

ECARX Starts Mass Production of its Antora 1000 computing platform for the Lynk & Co 06 SUV

GlobeNewswire

8 months ago

ECARX Starts Mass Production of its Antora 1000 computing platform for the Lynk & Co 06 SUV

Applied UV Announces Third Quarter 2023 Financial Results, Revenue Increases to $11.4 Million, Adjusted EBITDA (non-GAAP) Improves 30.8% Year Over Year

GlobeNewswire

8 months ago

Applied UV Announces Third Quarter 2023 Financial Results, Revenue Increases to $11.4 Million, Adjusted EBITDA (non-GAAP) Improves 30.8% Year Over Year

Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Oxbridge Re Holdings Limited (NASDAQ:OXBR) Q3 2023 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

ACCESSWIRE

8 months ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Blue Star Foods Signed 2-Year Bid Award Purchase Agreement with Sysco Corporation

GlobeNewswire

8 months ago

Blue Star Foods Signed 2-Year Bid Award Purchase Agreement with Sysco Corporation

Moleculin Reports Third Quarter 2023 Financial Results

PR Newswire

8 months ago

Moleculin Reports Third Quarter 2023 Financial Results

Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates

GlobeNewswire

9 months ago

Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Synchronoss Technologies, Inc. (NASDAQ:SNCR) Q3 2023 Earnings Call Transcript

iSun Inc. Announces Timing for Third Quarter 2023 Conference Call and Webcast

Business Wire

9 months ago

iSun Inc. Announces Timing for Third Quarter 2023 Conference Call and Webcast

Reuters

9 months ago

US CDC to expand surveillance of travelers for respiratory viruses

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

PR Newswire

9 months ago

Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens

All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy

Zacks

9 months ago

All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to Buy

NEXGEL Secures Supply Agreement with AbbVie

GlobeNewswire

9 months ago

NEXGEL Secures Supply Agreement with AbbVie

Share on Social Networks: